Latest news

September 4, 2024
/
News

US FDA Grants Clearance for DaylightRx

US FDA Grants Clearance for SleepioRx
August 8, 2024
/
News
Study Finds Spark Direct Effective in Improving Mood Among Adults With Depression
May 23, 2024
/
News
Running the Next Leg
April 2, 2024
/
News
The mental health system of the future, delivered today
January 2, 2024
/
News

All News

New Research Demonstrates Clinical Effectiveness of Digital Treatment at Improving Insomnia and Comorbid Mental and Physical Health Issues
Findings advance the clinical evidence foundation demonstrating that Sleepio, a digital cognitive behavioral therapeutic for insomnia, is a safe and effective, non-drug alternative to treating global, co-occurring conditions
October 9, 2023
/
News
New Research Demonstrates Clinical Effectiveness of Digital Treatment at Improving Insomnia and Comorbid Mental and Physical Health Issues
Findings advance the clinical evidence foundation demonstrating that Sleepio, a digital cognitive behavioral therapeutic for insomnia, is a safe and effective, non-drug alternative to treating global, co-occurring conditions
October 9, 2023
/
News
Supporting clinicians with effective digital treatments
Big Health partners with the American Psychological Association to increase awareness of the value and impact of digital treatments in clinical care delivery.
August 10, 2023
/
News
Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix
Big Health partners with the American Psychological Association to increase awareness of the value and impact of digital treatments in clinical care delivery.
July 14, 2023
/
News
Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix
Leader in Digital Therapeutics Adds to Existing Insomnia and Anxiety Treatments to Address the Youth Mental Health Crisis
July 14, 2023
/
News
Accelerating Our Mission, Expanding Our Platform
Big Health Adds Clinically Proven Digital Therapeutics to Treat Adolescent Depression and Anxiety
July 14, 2023
/
News
Let's talk
For all media-related queries, please get in touch with us.
Who we are
Learn about our mission, leadership, advisors, and investors.